Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Study Links Recurrence Of Abnormal Cervical Cells To Age, Treatment Type
Older women, women with a higher grade of precancerous cells and women who undergo a freezing procedure known as cryotherapy to remove abnormal cervical cells are at a higher risk than other groups that the problem cells will return or develop into cervical cancer, according to a study published in the Journal of the National Cancer Institute, Reuters reports. For the study, Joy Melnikow of the University of California-Davis and colleagues compared 37,000 women who were treated for cervical intraepithelial neoplasia -- abnormal cervical cells -- from 1986 through 2000 with 71,000 women who had no history of abnormal cervical cells.The researchers found that the risk of cervical cancer and recurrence of medium to severe degrees of CIN was highest for women who were older than age 40, who had been previously treated for severe CIN or whose abnormal cells were treated using cryotherapy. The women underwent cone biopsies a surgical procedure to remove abnormal cells were least likely to have a recurrence of CIN. According to Melnikow, recurrence was most likely to occur within the first six years after treatment. Melnikow said that women who have been treated surgically have higher risks of bleeding and preterm labor. Therefore, younger women who are planning to become pregnant might prefer cryotherapy, she said, adding that younger women"s "risk of recurrence is lower, and a recurrence can be treated again" (Steenhuysen, Reuters, 5/12).
generic viagra online
Bariatric Surgery Patients Have 67 Percent Lower Chance Of Complications At Top Hospitals: Study
The HealthGrades Fourth Annual Bariatric Surgery Trends in American Hospitals Study released today identifies 88 hospitals as "best" performers (five-star rated), with mortality rates, complication rates and patient lengths of stay that are dramatically lower than poorly rated hospitals.
News of the day
Amylin Pharmaceuticals Announces Positive Results From Dose-Ranging Clinical Study Of Pramlintide/Metreleptin Combination Treatment For Obesity
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced positive results from a 28-week dose-ranging study of pramlintide/metreleptin, a combination treatment comprising pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin, in overweight and obese patients. This Phase 2 study successfully characterized patients who responded best to treatment and also provided important information to inform dose selection.
Cardiovascular

Wiley-Blackwell To Publish Journal Of Diabetes Investigation

Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc (NYSE: JWa), (NYSE: JWb), has announced that it will be publishing a new diabetes journal titled Journal of Diabetes Investigation from 2010. Published bi-monthly, the official journal of the Asian Association for the Study of Diabetes (AASD), Journal of Diabetes Investigation will publish both basic and clinical research in diabetes - including a variety of original research, country reports, commentaries, reviews; mini-reviews case reports letters as well as editorials and news. The President of the AASD, Professor Yutaka Seino, said, "The rapid increase in the number of diabetes patients will dramatically impact the medical profession in Asia and will require increasing research on the disease specifically among Asians. The AASD will aggressively promote research activity with the aim of promptly improving diabetes treatments and care for a vast number of Asian patients." The Editor-in-chief of the journal, Nigishi Hotta, said, "The journal will have an international editorial team of experts from the AASD countries and beyond, and will embrace clinical and experimental research in diabetes and its related areas - including aspects of prevention, treatment, education, nutrition, metabolic risk, psychosocial and socio-economic research, as well as molecular aspects and pathophysiology. We seek to develop Journal of Diabetes Investigation to position it as the core diabetes journal of Asia. Wiley-Blackwell, with its international publishing expertise and experience of publishing in cooperation with medical societies in Asia, is the ideal partner to enable the editorial board to meet its goals." The President of the Japan Diabetes Society, Professor Takashi Kadowaki, added, "We are delighted to be publishing with Wiley-Blackwell and look forward to working with the team to communicate ground- breaking research and exciting discoveries to the world"s research communities and health care professionals." The Medical Editorial Director of Wiley-Blackwell, Neil Christensen, remarked, "The significant society involvement - in addition to an editorial board of such high caliber - will make this a project to be reckoned with in terms of authority. We"re very well positioned to help the Journal of Diabetes Investigation realize its full potential and increase its visibility to readers both within North Asia as well as worldwide. The addition of this journal will also strengthen our position as a leading publisher of choice for societies and organizations focused on all aspects of diabetic health and endocrinology research. "ò€‚ò€‚ò€‚ Wiley-Blackwell


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009